"Urologic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the URINARY TRACT in either the male or the female.
| Descriptor ID |
D014571
|
| MeSH Number(s) |
C04.588.945.947 C12.758.820 C13.351.937.820
|
| Concept/Terms |
Urologic Neoplasms- Urologic Neoplasms
- Urological Neoplasms
- Neoplasm, Urological
- Neoplasms, Urological
- Urological Neoplasm
- Urinary Tract Neoplasms
- Neoplasm, Urinary Tract
- Neoplasms, Urinary Tract
- Tract Neoplasm, Urinary
- Tract Neoplasms, Urinary
- Urinary Tract Neoplasm
- Neoplasms, Urologic
- Neoplasm, Urologic
- Urologic Neoplasm
Cancer of Urinary Tract- Cancer of Urinary Tract
- Urinary Tract Cancers
- Urological Cancer
- Cancer, Urological
- Cancers, Urological
- Urological Cancers
- Cancer of the Urinary Tract
- Urinary Tract Cancer
- Cancer, Urinary Tract
- Cancers, Urinary Tract
- Urologic Cancer
- Cancer, Urologic
- Cancers, Urologic
- Urologic Cancers
|
Below are MeSH descriptors whose meaning is more general than "Urologic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Urologic Neoplasms".
This graph shows the total number of publications written about "Urologic Neoplasms" by people in this website by year, and whether "Urologic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 2000 | 2 | 0 | 2 |
| 2006 | 1 | 2 | 3 |
| 2007 | 1 | 0 | 1 |
| 2008 | 4 | 0 | 4 |
| 2009 | 1 | 0 | 1 |
| 2010 | 3 | 0 | 3 |
| 2012 | 3 | 0 | 3 |
| 2013 | 3 | 0 | 3 |
| 2014 | 2 | 0 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 3 | 0 | 3 |
| 2017 | 3 | 1 | 4 |
| 2018 | 5 | 0 | 5 |
| 2019 | 5 | 0 | 5 |
| 2020 | 8 | 1 | 9 |
| 2021 | 4 | 0 | 4 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 1 | 2 |
| 2024 | 2 | 4 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Urologic Neoplasms" by people in Profiles.
-
ACR Appropriateness Criteria® Pretreatment Staging of Urothelial Cancer: 2024 Update. J Am Coll Radiol. 2024 Nov; 21(11S):S464-S489.
-
Prevalence of unnecessary kidney function exclusion criteria in urologic oncology clinical trials. Urol Oncol. 2024 Dec; 42(12):452.e15-452.e19.
-
Rogaratinib Plus Atezolizumab in Cisplatin-Ineligible Patients With FGFR RNA-Overexpressing Urothelial Cancer: The FORT-2 Phase 1b Nonrandomized Clinical Trial. JAMA Oncol. 2024 Nov; 10(11):1565-1570.
-
Estimating the Size and Scope of the Urologic Oncology Clinical Trials Enterprise. Urol Pract. 2024 Jul; 11(4):627-629.
-
[Rare tumors and tumor types of the urinary system in the 5th edition of the WHO classification 2022]. Pathologie (Heidelb). 2024 Nov; 45(6):381-388.
-
Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy. Eur Urol. 2024 Jun; 85(6):574-585.
-
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma. Eur Urol Oncol. 2024 Aug; 7(4):933-943.
-
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations. JCO Precis Oncol. 2023 07; 7:e2300095.
-
Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin. Oncologist. 2022 03 11; 27(3):e223-e232.
-
The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia. Adv Anat Pathol. 2021 Jul 01; 28(4):179-195.